|
|
Exchange: |
OTC Bulletin Board |
Security
Type: |
Common |
Shares
Out: |
149,990,000 |
Market
Cap: |
137.98(M) |
Last
Volume: |
394,168 |
Avg
Vol: |
182,850 |
52
Week Range: |
$0.9199 - $0.9199 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Lineage Cell Therapeutics is a clinical-stage biotechnology company developing cell therapies. Co. has several allogeneic cell therapy programs in development: OpRegen®, a retinal pigment epithelium cell replacement therapy for the treatment of advanced dry age-related macular degeneration with geographic atrophy; OPC1, an oligodendrocyte progenitor cell therapy for spinal cord injuries; VAC, an allogeneic cancer immunotherapy of antigen-presenting dendritic cells; and other product candidates in preclinical development covering a range of therapeutic areas and target tissues or organs. Co. has rights to HyStem, a patented biomaterial that mimics naturally occurring extracellular matrix.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
96,155 |
6,836,925 |
6,836,925 |
6,836,925 |
Total Buy Value |
$100,001 |
$7,110,902 |
$7,110,902 |
$7,110,902 |
Total People Bought |
1 |
3 |
3 |
3 |
Total Buy Transactions |
1 |
4 |
4 |
4 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,687 |
83,958 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-07-10 |
4 |
D |
$3.09 |
$1,814 |
D/D |
(587) |
880,864 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-07-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,562 |
881,451 |
|
- |
|
Andrews Deborah J |
Director |
|
2017-06-16 |
4 |
B |
$2.95 |
$5,900 |
D/D |
2,000 |
6,000 |
2.39 |
- |
|
Andrews Deborah J |
Director |
|
2017-05-16 |
4 |
B |
$3.21 |
$6,410 |
D/D |
2,000 |
4,000 |
2.39 |
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-04-10 |
4 |
D |
$3.33 |
$23,463 |
D/D |
(7,046) |
79,271 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2017-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
18,750 |
86,317 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-04-10 |
4 |
D |
$3.33 |
$7,819 |
D/D |
(2,348) |
879,889 |
|
- |
|
West Michael D |
Co-Chief Executive Officer |
|
2017-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,250 |
882,237 |
|
- |
|
Bradsher Neal C |
Director |
|
2017-02-15 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
27,119,254 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2017-02-15 |
4 |
B |
$2.70 |
$5,999,999 |
D/D |
2,222,222 |
27,119,254 |
3.92 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2017-01-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(238,469) |
1,143,346 |
|
- |
|
Kingsley Alfred D |
See Remarks |
|
2017-01-03 |
4 |
D |
$0.00 |
$0 |
I/I |
(238,469) |
1,143,346 |
|
- |
|
Greenbelt Corp /ny |
See Remarks |
|
2017-01-03 |
4 |
D |
$0.00 |
$0 |
D/D |
(238,459) |
1,143,346 |
|
- |
|
Kingsley Alfred D |
See Remarks |
|
2016-12-01 |
5 |
GD |
$0.00 |
$0 |
I/I |
69,300 |
1,381,805 |
|
- |
|
Knight James A. |
Sr VP, Head of Corporate DevOf |
|
2016-10-19 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
17,704 |
|
- |
|
Knight James A. |
Sr VP, Head of Corporate DevOf |
|
2016-10-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
17,036 |
|
- |
|
Bradsher Neal C |
Director |
|
2016-06-21 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
24,897,032 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2016-06-21 |
4 |
B |
$2.39 |
$6,531,000 |
D/D |
2,732,636 |
24,897,032 |
3.92 |
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2016-04-11 |
4 |
A |
$2.96 |
$199,998 |
D/D |
67,567 |
67,567 |
|
- |
|
Mohanty Aditya P. |
Co-Chief Executive Officer |
|
2016-04-11 |
4 |
A |
$2.96 |
$199,998 |
D/D |
67,567 |
67,567 |
|
- |
|
Segall Judith |
Vice President & Secretary |
|
2016-04-06 |
5 |
GD |
$3.25 |
$6,175 |
D/D |
1,900 |
591,245 |
|
- |
|
Bradsher Neal C |
Director |
|
2016-01-20 |
4 |
B |
$0.00 |
$0 |
I/I |
0 |
22,164,396 |
2.17 |
- |
|
Bradsher Neal C |
Director |
|
2016-01-20 |
4 |
B |
$2.35 |
$705,000 |
D/D |
300,000 |
22,164,396 |
3.92 |
- |
|
Kingsley Alfred D |
See Remarks |
|
2016-01-20 |
4 |
S |
$2.35 |
$705,000 |
D/D |
(300,000) |
5,638,055 |
|
- |
|
194 Records found
|
|
Page 6 of 8 |
|
|